BioReact, based in Indianapolis, uses AI and analytics to improve bioprocess development and has received investments from the University of Tulsa and Hurricane Ventures.
The amount of the deal was not disclosed.
Read More:Republic Business Credit Provides $3 Million to Help Textile Company Grow
The company plans to use the funds to speed up sales efforts and improve its products.
Hurricane Ventures invests in early-stage companies connected to the University of Tulsa. The fund leverages the university’s knowledge and resources to support innovation, help its portfolio companies succeed, and boost regional economic growth.
BioReact offers a single system that organizes data from multiple sources into a single, structured platform. Scientists using bioreactors—containers where cells are grown to make medicines and vaccines—usually spend four to five hours manually sorting data from devices, spreadsheets, and lab notebooks before they can study the results.
BioReact allows scientists to upload data from different sources and automatically organize it, showing results in seconds. Its AI analyzes factors such as temperature, pH, and nutrient levels to identify optimal growth conditions, thereby increasing yields, reducing costs, and accelerating development. The platform is easy to use, requires no coding, and can be applied across industries such as biopharma, industrial biotech, and synthetic biology.
Castetter has over ten years of experience in biotech sales at Beckman Coulter and Cytena. His co-founder, Joanna Lipinski, has more than 20 years of experience in high tech and biotech, specializing in creating advanced software and data platforms for modern scientific research.
“The support from the University of Tulsa and Hurricane Ventures helps us speed up the development of software that truly helps scientists,” said Mitchell Castetter, CEO and co founder. “Besides the funding, access to UTulsa’s top biotech talent gives us an advantage in improving the product with real scientific expertise, making sure BioReact keeps providing useful tools for teams managing complex bioprocesses.”
“We’re excited to support this team as they update the bioprocess workflow and help speed up the development of medicines and other important products,” said Connor Sitton, director of Hurricane Ventures.
About BioReact
Founded in 2023 by CEO Mitchell Castetter and co founder Joanna Lipinski, BioReact offers an AI and analytics platform for modern bioprocess development and optimization. Its system lets teams combine data from multiple sources into one organized platform. The AI analyzes factors such as temperature, pH and nutrient levels to identify the optimal growth conditions, helping increase yields, reduce costs, and accelerate development. The platform is easy to use, requires no coding, and works across industries such as biopharma, industrial biotech, and synthetic biology.
About Hurricane Ventures
Founded in April 2023, Hurricane Ventures is a joint venture between FortySix Capital LLC, and the University of Tulsa. It invests in early-stage, fast-growing companies led by UTulsa students, staff, alums and partners. Using the university’s resources and alums network, Hurricane Ventures helps founders launch and grow their businesses. The fund invests in many industries but focuses on areas where the university has strong expertise.
Read More:Helia Care Raises $3M in Funding
